Biofourmis Closes $463.6M to Advance AI-Driven Care

Biofourmis has secured $463,600,000 in its latest funding round.

The global technology company focuses on enabling care delivery by bringing hospital-level services and virtual care to patients in their homes.

This is achieved through an AI-driven solution that collects and analyzes over 120 biomarkers in real time.

Biofourmis’ innovation identifies shifts in patient data that require proactive interventions, allowing for connected access to services, virtual provider networks for remote care, and life-changing clinical trials, all without patients leaving their homes.

Trusted by leading health systems, payers, and biopharma companies, Biofourmis' connected platform aims to improve patient outcomes, prevent hospital readmissions, and accelerate drug development.

The company's mission is to make science smarter, healthcare simpler, and patients healthier by closing critical gaps in care.

This significant capital infusion underscores investor confidence in Biofourmis' model for decentralized healthcare and its potential to transform patient care delivery globally.

The company plans to strategically deploy the new capital to accelerate its growth initiatives, further developing its AI-driven platform and expanding its reach to more patients and partners worldwide.

This investment will support Biofourmis in scaling its efforts to provide accessible, high-quality care outside traditional clinical settings.

With this substantial funding, Biofourmis is well-positioned to advance its mission of redefining healthcare delivery, enhancing its technological capabilities, and extending its impact on patient lives through innovative at-home care solutions.